Nonsurgical treatments of esophageal cancers;Traitements non chirurgicaux des cancers de l'oesophage

Revue de Medecine Interne

Volumn 21, Issue 1, 2000, Pages 58-73

  Conroy, T ^a,c   Kaminsky, M C ^a   Peiffert, D ^b   Wolff, P ^b  

^a Departement d'Oncologie Medicale   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c CHU NANCY BRABOIS   (France)

Author keywords

Chemotherapy; Combined modality therapy; Esophageal carcinoma; Palliation; Radiotherapy

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA; IFOSFAMIDE; IRINOTECAN; LOBAPLATIN; METHOTREXATE; MITOGUAZONE; MITOMYCIN C; NAVELBINE; PACLITAXEL; TRIMETREXATE; VINBLASTINE; VINDESINE;

CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; HUMAN; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; REVIEW;

EID: 0033958505     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)87229-X     Document Type: Article

References (81)

1. La Vecchia C, Negri E, Levi F, Decarli A, Boyle P. Cancer mortality in Europe: Effects of age, cohort of birth and period of death. Eur J Cancer 1998 ; 34 : 118-41.
2. Ménégoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buémi A, et al. Cancer incidence and mortality in France in 1975-95. Eur J Cancer 1997 ; 6 : 442-66.
3. Calament G, Cauvin JM, Robaszkiewicz M, Nousbaum JB, Lepage M, Robert FX, et al. Traitement et survie du cancer épidermoïde de l'œsophage dans le département du finistère entre 1984 et 1988 (716 cas). Gastroentérol Clin Biol 1993 ; 17 : 9-16.
4. Kok TC. Chemotherapy in esophageal cancer: A review. Cancer Treat Rev 1997 ; 23 : 65-85.
5. Agha FP, Gennis MA, Orringer MB, Forastiere AA. Evaluation of response to preoperative chemotherapy in esophageal and gastric cardia cancer using biphasic esophagrams and surgical-pathologic correlation. Am J Clin Oncol 1986 ; 9 : 227-32.
6. Conroy T. Measurement of the primary esophageal tumor. In: EORTC Gastrointestinal Tract Cancer Cooperative Group: Manual on Diagnosis and Treatment of Gastrointestinal Tract Cancer. Wils J, Bleiberg H, eds. Brentwood: Multiscience Publishing Co; 1993. p. 28-30.
7. François E, Olivier JM, Rougier P, Roussel A, Seitz JF, Toma C. Standards, options et recommandations pour la prise en charge des patients atteints de cancer de l'œsophage. In: Standards, Options & Recommandations. Recommandations pour la pratique clinique. FNCLCC éd. CD ROM. Paris: John Libbey Eurotext ; 1998.
8. Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G. Jacob JH. et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell œsophageal cancer. Eur J Cancer 1997 ; 33 : 1216-20.
9. Conroy T, Étienne PL, Adenis A, Wagener DJT, Paillot B, François E, et al. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. J Clin Oncol 1996 ; 14 : 164-70.
10. Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 1994 ; 86 : 1086-91.
11. Lokich JJ, Shea M, Chaffey J. Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer 1987 ; 60 : 275-9.
12. Ezdinli EZ, Gelber R, Desai DV, Falkson G, Moertel CG. Hahn RG. Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience. Cancer 1980 ; 46 : 2149-53.
13. Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, et al. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 1998 ; 16 : 1826-34.
14. Charlois T, Burtin P, Ben Bouali A, Ferrero P, Person B, Charneau J, et al. Facteurs prédictifs de réponse à la chimiothérapie du cancer épidermoïde de l'œsophage. Étude à propos de 60 patients et élaboration d'un score de réponse. Gastroentérol Clin Biol 1992 ; 16 : 134-40.
15. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992 ; 16 : 1104-10.
16. Kelsen DP, Minsky B, Smith M, Beitler J, Niedzwiecki D, Chapman D, et al. Preoperative therapy for esophageal cancer: A randomized comparison of chemotherapy versus radiation therapy. J Clin Oncol 1990 ; 8 : 1352-61.
17. Maipang T, Vasinanukorn P, Petpichetchian C, Chamroonkul S, Geater A, Chansawwaang S, et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994 ; 56 : 191-7.
18. Roth A, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988 ; 96 : 242-8.
19. Resbeut M, Chenal C, Vignoud J, Malhaire JP, Chaillet MP, Leprisé E, et al. Results of a randomized neoadjuvant program of chemotherapy before surgery and/or radiotherapy in the treatment of 156 esophageal carcinoma. Second International Congress on Neoadjuvant Chemotherapy, Paris, 1988. p. 49.
20. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992 ; 127 : 1446-50.
21. Law S, Fok M, Chow S, Chu KM, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial. J Thorac Cardiovasc Surg 1997 ; 114: 210-7.
22. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998 ; 339 : 1979-84.
23. Kok TC, Lanschot JV, Siersema PD, Overhagen HV, Tilanus HW. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: Final report of a phase III multicenter randomized controlled study. Proc Am Soc Clin Oncol 1997 ; 16 : 277.
24. Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 1993 ; 104 : 203-7.
25. Ando N. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997 ; 114 : 205-9.
26. Pearson JG. The present status and future potential radiotherapy in the management of oesophageal cancer. Cancer 1977 ; 39 : 882-6.
27. Sykes AJ, Burt PA, Slevin NJ, Stout R, Marrs JE. Radical radiotherapy for carcinoma of the oesophagus: An effective alternative to surgery. Radiother Oncol 1998 ; 48 : 15-21.
28. Girinsky T, Auperin A, Marsiglia H, Dhermain F, Randrianarivelo H, Kac J, et al. Accelerated fractionation in esophageal cancers: A multivariate analysis on 88 patients. Int J Radiat Oncol Biol Phys 1997 ; 38 : 1013-8.
29. Newaishy GA, Read GA. Duncan W, Kerr GR. Results of radical radiotherapy of squamous cell carcinoma of the esophagus. Clin Radiol 1982 ; 33 : 347-52.
30. Slevin NJ, Stout R. Carcinoma of the esophagus: A review of 108 cases treated by radical radiotherapy. Clin Radiol 1989 ; 40 : 200-3.
31. Harrison LN, Fogel TD, Picone JR, Fischer DB, Weissberg JB. Radiation therapy for carcinoma of the esophagus. J Surg Oncol 1998 ; 37 : 40-3.
32. De-Ren S. Ten-year follow-up of esophageal cancer treated by radical radiation therapy: Analysis of 869 patients. Int J Radiat Oncol Biol Phys 1989 ; 16 : 329-34.
33. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, VaitKevicius VK, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997 ; 15 : 277-84.
34. Araujo CMM, Souhami L, Gil RA, Carvalho R, Garcia JA, Froimtchuk MJ, et al. A randomised trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991 ; 67 : 2258-61.
35. Smith TJ, Ryan LM, Douglass HO, Haller DG, Yogeshwar D, Kirkwood J, et al. Combined chemoradiotherapy versus radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998 ; 42 : 269-76.
36. Arnott SJ, Duncan W, Gignoux M, Girling DJ, Hansen HS, Launois B, et al. Preoperative radiotherapy in esophageal carcinoma: A metaanalysis using individual patient data (esophageal cancer collaborative group). Int J Radiat Oncol Biol Phys 1998 ; 41 : 579-83.
37. Micaily B, Miyamoto C, Freire J, Brady L. Intracavitary brachytherapy for carcinoma of the esophagus. Semin Surg Oncol 1997 ; 13 : 185-9.
38. Steiger Z, Franklin R, Wilson RF, Leichman L, Seydel H, Lok JJ, et al. Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy and surgical therapy. J Thorac Cardiovasc Surg 1981 ; 82 : 713-9.
39. Leichman L, Steiger Z, Seydel HG, Dindogru A, Kinzie JV, Toben S, et al. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: A potentially curative approach. J Clin Oncol 1984 ; 2 : 75-9.
40. Poplin E, Fleming T, Leichman L, Seydel HG, Steiger Z, Taylor S, et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 1987 ; 5 : 622-8.
41. Seydel HG, Leichman L, Byhardt R, Cooper J, Herskovic A, Libnock J, et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: A RTOG study. Int J Radiat Oncol Biol Phys 1988 ; 14 : 33-5.
42. Herskovic A, Leichman L, Lattin P, Han I, Ahmad K, Leichman G, et al. Chemoradiation with and without surgery in the thoracic esophagus: The Wayne state experience. Int J Radiat Oncol Biol Phys 1988 ; 15 : 655-62.
43. Gignoux M, Bosset JF, Apoil B, Gillet M, Triboulet JP, Ollivier JM, et al. Radio-chimiothérapie adjuvante dans les cancers opérables de l'œsophage thoracique. Résultats préliminaires d'une étude multicentrique. Étude portant sur 119 cas. Ann Chir 1989 ; 43 : 269-74.
44. Stewart FM, Harkins BJ. Hahn SS, Daniel TM. Cisplatin, 5 fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophagectomy for esophageal carcinoma. Cancer 1989 ; 64 : 622-8.
45. Forastière AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993 ; 11 : 1118-23.
46. Bidoli P. Spinazze S. Valente M. Zucali R, Prada A, Cantu G. et al. Combined chemotherapy (CT)-radiotherapy (RT) and esophagectomy (E) in squamous cell cancer of the esophagus (SCCE). Proc Am Soc Clin Oncol 1990 ; 9 : 110.
47. Laterza E, Griso C, Urso US, De Manzoni G, Malago M, Oliani C, et al. Induction therapy for squamous carcinoma of thoracic esophagus. Ann Thorac Surg 1994 ; 57 : 1126-32.
48. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996 ; 14 : 156-63.
49. Ganem G, Dubray B, Raoul Y, Colin P, Bardet E, Douillard JY, et al. Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus. J Clin Oncol 1997 ; 15 : 701-11.
50. Bedenne L, Seitz JF, Milan C, Renard P, Fraisse J, Conroy T, et al. Cisplatine, 5-FU et radiothérapie préopératoire dans les cancers épidermoïdes de l'œsophage. Gastroentérol Clin Biol 1998 ; 22 : 273-81.
51. Andersen AP, Berdal P, Edsmyr F, Hagen S, Hatlevoll R, Nygaard K, et al. Irradiation, chemotherapy and surgery in esophageal cancer: A randomized clinical study. The first Scandinavian trial in esophageal cancer. Radiother Oncol 1984 ; 2 : 179-88.
52. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatol Gastroenterol 1994 ; 41 : 391-3.
53. Walsh TN, Noonan N, Hollywood D, Kelly A, Stat C, Keeling N, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996 ; 335 : 462-7.
54. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997 ; 337 : 161-7.
55. Urba S, Orringer M, Turrisi A, Whyte R, Iannettoni M, Forastiere A. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: Updated analysis. Proc Am Soc Clin Oncol 1997 ; 16 : 277.
56. Leprisé E, Étienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al. A randomized study of chemotherapy radiation therapy, and surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994 ; 73 : 1779-84.
57. Coia LR, Engstrom PF, Paul A. Nonsurgical management of esophageal cancer: Report of a study of combined radiotherapy and chemotherapy. J Clin Oncol 1987 ; 5 : 1783-90.
58. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5 FU, mitomycin C, and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991 ; 20 : 29-36.
59. Keane TJ, Harwood AR, Elhakim T, Rider WD, Cummings BJ, Ginsberg RJ, et al. Radical radiation therapy with 5 fluorouracil infusion and mitomycin C for esophageal squamous carcinoma. Radiother Oncol 1985 ; 4 : 205-10.
60. John MJ, Flam MS, Ager Mowry PA, Podolsky WJ, Xavier AM, Wittlinger PS, et al. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989 ; 63 : 2397-403.
61. Leichman L, Herskovic A, Leichman CG, Lattin PB, Steiger S, Tapazoglou E, et al. Nonoperative therapy for squamous cell cancer of the esophagus. J Clin Oncol 1987 ; 5 : 365-70.
62. Seitz JF, Giovannini M, Padaut-Cesana J, Fuentes P, Giudicelli R, Gauthier AP, et al. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 1990 ; 66 : 214-9.
63. Seitz JF, Milan C, Dumas F, Cauvin JM, Conroy T, François E. Radio-chimiothérapie concomitante concentrée dans les cancers épidermoïdes de l'œsophage : Résultats d'un essai de phase II multicentrique de la FFCD chez 119 patients non opérables. Gastroénterol Clin Biol 1995 ; 19 : 21.
64. Earle JD, Gelber RD, Moertel CG, Hahn RG. A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Oncol Biol Phys 1980 ; 6 : 821-6.
65. Roussel A, Haegelé P, Paillot B, Gignoux M, Marinus A, Sahmoud T, et al. Results of the EORTC-GTCCG phase III trial of irradiation vs irradiation and CDDP in operable esophageal cancer. Proc Am Soc Clin Oncol 1994 ; 13 : 199.
66. Kolaric K, Zupanc D, Zivkovic M. Radiation alone vs radiochemotherapy (DDP+ 5FU) in locoregionally advanced esophageal cancer. Interim report of a prospective randomized study. Proc Am Soc Clin Oncol 1992 ; 11 : 175.
67. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992 ; 326 : 1593-8.
68. Naveau S, Ratziu V, Chaput JC. Traitement endoscopique palliatif des sténoses malignes de l'oesophage et du cardia. Gastroentérol Clin Biol 1993 ; 17 : 740-6.
69. Loizou LA, Rampton D, Atkinson M, Robertson C, Bown SG. A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia. Cancer 1992 ; 70 : 386-91.
70. Maunoury V, Brunetaud JM, Cochelard D, Boniface B, Cortot A, Paris JC. Endoscopic palliation for inoperable malignant dysphagia: Long-term follow-up. Gut 1992 ; 33 : 1602-7.
71. Gevers AM, Macken E, Hiele M, Rutgeerts P. A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula. Gastrointest Endosc 1998 ; 48 : 383-8.
72. Naveau S, Chiesa A, Poynard T, Chaput JC. Endoscopic Nd-YAG laser therapy as palliative treatment for oesophageal and cardial cancer. Dig Dis Sci 1990 ; 35 : 294-301.
73. Bourke M, Hope R, Chu G, Gillespie P, Bull C, O'Rourke I, et al. Laser palliation of inoperable malignant dysphagia: Initial and at death. Gastrointest Endosc 1996 ; 43 : 29-32.
74. Loizou LA, Grigg D, Atkinson M, Robertson C, Bown SG. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology 1991 ; 100 : 1303-10.
75. Kozarek R, Ball T, Brandabur J, Patterson D, Low D, Hill L, et al. Expandable versus conventional oesophageal prostheses: Easier insertion may not preclude subsequent stent-related problems. Gastrointest Endosc 1996 ; 43 : 204-8.
76. De Palma G, Di Matteo E, Romano G, Fimmano A, Rondinone G, Catanzano C. Plastic prosthesis versus expandable metal stents for palliation of inoperable oesophageal thoracic carcinoma: A controlled prospective study. Gastrointest Endosc 1996 ; 43 : 478-82.
77. Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993 ; 329 : 1302-7.
78. Scheider DM, Saidi R, Ross C, Cirocco M, Siemens M, Haber GB, et al. Photodynamic therapy (PDT) for treatment of tumor ingrowth in expandable oesophageal stents (EES). Endoscopy 1993 ; 29 : 271-4.
79. Spencer GM, Thorpe SM, Sargeant IR, Blackman GM, Solano J, Tobias JS. Laser and brachytherapy in the palliation of adenocarcinoma of the oesophagus and cardia. Gut 1996 ; 39 : 726-31.
80. Conio M, Bonelli L, Martines H, Munizzi F, Aste H. Palliative bipolar electrocoagulation treatment of malignant gastroesophageal strictures. Surg Endosc 1990 ; 4 : 164-7.
81. Angelini G, Fratta-Pasini A, Ederle A, Castagnini A, Talamini G, Bulighin G. Nd-YAG laser versus polidocanol injection for palliation of oesophageal malignancy: A prospective, randomized study. Gastrointest Endosc 1991 ; 37 : 607-10.